Patent · US Active

Compounds which modulate the CB2 receptor

US8299111B2 · kind B2 · utility

12Cited by

37References

9Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Angela Berry · Gaylordsville, US
Pier Francesco Cirillo · Woodbury, US
Eugene Richard Hickey · Danbury, US
Doris Riether · Biberach an der Riß, DE
David Thomson · Ridgefield, US
Monika Ermann · Wantage, GB
James Edward Jenkins · Hungerford, GB
Innocent Mushi · Felton, GB
Christopher Francis Palmer · Abingdon, GB
Nigel James Blumire · Biggenden, AU

Key dates

Filing date	Nov 30, 2010
Grant date	Oct 30, 2012
Priority date	—
Expiry date	Nov 30, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I)are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.